LEGN Legend Biotech Corporation
$18.64▼ -2.87%
Healthcare
Other
After hours
$18.85▲ +1.13%
Sep 11, 7:30 PM ET
Volume 4.27M
Avg Volume (10D) 1.43M
Key Metrics & Fundamentals
Market Cap
$3.63B
P/E Ratio
–
Div Yield
–%
52W Range
16.24 - 37.50
% vs 50 MA
-14.97%
% vs 200 MA
-18.82%
RSI-14
35.6
MACD Histogram
-0.1200
Beta (1Y vs SPY)
0.49
Free Cash Flow
-$28.40M
Gross Rev
$387.50M
Gross Profit
$250.10M
EBITDA
$75.50M
COGS
$137.40M
Operating Exp
$192.40M
Operating Income
$57.70M
EBIT
$57.70M
Pretax Income
$55.50M
Net Income
$33.20M
EPS (Diluted)
0.18
Price & Volume History
Loading chart…
Recent News
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
GlobeNewswire · Sep 10, 2026 12:00 PM
Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?
Simply Wall St. · Sep 2, 2026 6:10 AM
Legend Biotech (LEGN) Stock May Be Undervalued Despite A 70% 3 Year Fall
Simply Wall St. · Sep 1, 2026 3:10 PM
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 12:00 PM
The hidden scale-out problem behind CAR-T’s growth
Pharma Voice · Sep 1, 2026 9:08 AM
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires · Aug 12, 2026 7:58 PM
Legend Biotech Shares Fall After Oppenheimer Downgrade
MT Newswires · Aug 12, 2026 6:20 PM
Sector Update: Healthcare Stocks Ease in Afternoon Trading
MT Newswires · Aug 12, 2026 5:34 PM
Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says
MT Newswires · Aug 12, 2026 3:58 PM
Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says
MT Newswires · Aug 12, 2026 3:01 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LEGN's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.